ABT-538 is a Potent Inhibitor of Human Immunodeficiency Virus Protease and has High Oral Bioavailability in Humans

Authors: Kempf, Dale J., Marsh, Kennan C., Denissen, Jon F., McDonald, Edith, Vasavanonda, Sudthida, Flentge, Charles A., Green, Brian E., Fino, Lynnmarie, Park, Chang H., Kong, Xiang-Peng, Wideburg, Norman E., Saldivar, Ayda, Ruiz, Lisa, Kati, Warren M., Sham, Hing L., Robins, Terry, Stewart, Kent D., Hsu, Ann, Plattner, Jacob J., Leonard, John M., Norbeck, Daniel W.

Source: Proceedings of the National Academy of Sciences of the United States of America, 1995 Mar . 92(7), 2484-2488.

Access URL: https://www.jstor.org/stable/2367144

Design of orally bioavailable, symmetry-based inhibitors of HIV protease

Authors: Kempf, Dale J., Marsh, Kennan C., Fino, Lynnmarie Codacovi, Bryant, Pamela, Craig-Kennard, Adrienne, Sham, Hing L., Zhao, Chen, Vasavanonda, Sudthida, Kohlbrenner, William E., Wideburg, Norman E., Saldivar, Ayda, Green, Brian E., Herrin, Thomas, Norbeck, Daniel W.

Source: In Bioorganic & Medicinal Chemistry 1994 2(9):847-858